Press
back to blog

Entos (Now Iambic) Transforms Drug Discovery and Design With NVIDIA AI-Powered Molecular Simulation

Press
This is some text inside of a div block.
November 9, 2021

Media Contacts

Related announcements

View All
View All
September 5, 2024

Iambic Therapeutics Announces the Addition of Dr. Mary Tagliaferri to its Board of Directors

Read more
September 5, 2024

Iambic Therapeutics Announces the Addition of Dr. Mary Tagliaferri to its Board of Directors

Read more
June 18, 2024

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

Read more
June 18, 2024

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

Read more
June 18, 2024

How two academic chemists turned San Diego startup Iambic into an AI force

Read more
June 18, 2024

How two academic chemists turned San Diego startup Iambic into an AI force

Read more